Cargando…
The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia
Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearan...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575509/ https://www.ncbi.nlm.nih.gov/pubmed/28481056 http://dx.doi.org/10.1002/cm.21373 |
_version_ | 1783260060911140864 |
---|---|
author | Heckman, Carol A. Pandey, Pratima Cayer, Marilyn L. Biswas, Tania Zhang, Zhong‐Yin Boudreau, Nancy S. |
author_facet | Heckman, Carol A. Pandey, Pratima Cayer, Marilyn L. Biswas, Tania Zhang, Zhong‐Yin Boudreau, Nancy S. |
author_sort | Heckman, Carol A. |
collection | PubMed |
description | Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearance of filopodia was investigated by use of blocking peptides (BPs) that inhibit PKC maturation and/or docking. Filopodia were partially rescued by a peptide representing PKC ɛ hydrophobic sequence, but also by a myristoylated PKC α/β pseudosubstrate sequence, and an inhibitor of T‐cell protein tyrosine phosphatase (TC‐PTP). The ability to turn over filopodia was widely distributed among PKC isoforms. PKC α and η hydrophobic sequences enhanced filopodia in cells in the absence of tumor promoter treatment. With transcriptional knockdown of PKC α, the content of PKC ɛ predominated over other isoforms. PKC ɛ could decrease filopodia significantly in promoter‐treated cells, and this was attributed to ruffling. The presence of PKC α counteracted the PKC ɛ‐mediated enhancement of ruffling. The results showed that there were two mechanisms of filopodia downregulation. One operated in the steady‐state and relied on PKC α and η. The other was stimulated by tumor promoters and relied on PKC ɛ. Cycles of protrusion and retraction are characteristic of filopodia and are essential for the cell to orient itself during chemotaxis and haptotaxis. By suppressing filopodia, PKC ɛ can create a long‐term “memory” of an environmental signal that may act in nature as a mnemonic device to mark the direction of a repulsive signal. |
format | Online Article Text |
id | pubmed-5575509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55755092017-09-18 The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia Heckman, Carol A. Pandey, Pratima Cayer, Marilyn L. Biswas, Tania Zhang, Zhong‐Yin Boudreau, Nancy S. Cytoskeleton (Hoboken) Research Articles Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter‐stimulated disappearance of filopodia was investigated by use of blocking peptides (BPs) that inhibit PKC maturation and/or docking. Filopodia were partially rescued by a peptide representing PKC ɛ hydrophobic sequence, but also by a myristoylated PKC α/β pseudosubstrate sequence, and an inhibitor of T‐cell protein tyrosine phosphatase (TC‐PTP). The ability to turn over filopodia was widely distributed among PKC isoforms. PKC α and η hydrophobic sequences enhanced filopodia in cells in the absence of tumor promoter treatment. With transcriptional knockdown of PKC α, the content of PKC ɛ predominated over other isoforms. PKC ɛ could decrease filopodia significantly in promoter‐treated cells, and this was attributed to ruffling. The presence of PKC α counteracted the PKC ɛ‐mediated enhancement of ruffling. The results showed that there were two mechanisms of filopodia downregulation. One operated in the steady‐state and relied on PKC α and η. The other was stimulated by tumor promoters and relied on PKC ɛ. Cycles of protrusion and retraction are characteristic of filopodia and are essential for the cell to orient itself during chemotaxis and haptotaxis. By suppressing filopodia, PKC ɛ can create a long‐term “memory” of an environmental signal that may act in nature as a mnemonic device to mark the direction of a repulsive signal. John Wiley and Sons Inc. 2017-05-24 2017-08 /pmc/articles/PMC5575509/ /pubmed/28481056 http://dx.doi.org/10.1002/cm.21373 Text en © 2017 The Authors. Cytoskeleton Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Heckman, Carol A. Pandey, Pratima Cayer, Marilyn L. Biswas, Tania Zhang, Zhong‐Yin Boudreau, Nancy S. The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title | The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title_full | The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title_fullStr | The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title_full_unstemmed | The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title_short | The tumor promoter‐activated protein kinase Cs are a system for regulating filopodia |
title_sort | tumor promoter‐activated protein kinase cs are a system for regulating filopodia |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575509/ https://www.ncbi.nlm.nih.gov/pubmed/28481056 http://dx.doi.org/10.1002/cm.21373 |
work_keys_str_mv | AT heckmancarola thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT pandeypratima thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT cayermarilynl thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT biswastania thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT zhangzhongyin thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT boudreaunancys thetumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT heckmancarola tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT pandeypratima tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT cayermarilynl tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT biswastania tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT zhangzhongyin tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia AT boudreaunancys tumorpromoteractivatedproteinkinasecsareasystemforregulatingfilopodia |